Gentera, S.A.B. de C.V. (OTCMKTS:CMPRF) Short Interest Down 62.2% in July

Gentera, S.A.B. de C.V. (OTCMKTS:CMPRF – Get Free Report) was the target of a significant drop in short interest during the month of July. As of July 31st, there was short interest totaling 640,035 shares, a drop of 62.2% from the July 15th total of 1,692,597 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Gentera Price Performance

Gentera stock opened at $2.41 on Friday. Gentera has a 12 month low of $2.08 and a 12 month high of $2.67. The company has a fifty day moving average price of $2.25 and a two-hundred day moving average price of $2.37.

Get Gentera alerts:

Analyst Upgrades and Downgrades

Separately, Barclays reissued an “overweight” rating on shares of Gentera in a report on Friday, July 24th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has an average rating of “Buy”.

Check Out Our Latest Stock Analysis on Gentera

Gentera Company Profile

(Get Free Report)

Gentera is a Mexico-based financial services holding company focused on providing microfinance and digital banking solutions to underserved consumer and microenterprise segments. Through its primary subsidiary, Compartamos Banco, Gentera specializes in small-ticket, unsecured loans designed to foster income-generating activities and personal financial resilience. The company’s mission centers on responsible lending practices, financial inclusion and empowering clients through tailored credit products and financial education.

In addition to microcredit, Gentera offers a suite of complementary products including voluntary savings accounts, microinsurance policies and remittance services.

See Also

• Five stocks we like better than Gentera
• Asian Market Circuit Breakers Hit Stocks, Not AI Demand
• Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
• Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
• Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal

Receive News & Ratings for Gentera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gentera and related companies with MarketBeat.com's FREE daily email newsletter.